Genes and Cancer
SJR1.517
US
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 1.517 | Q1 | 92.2% | |
| 2024 | — | — | 1.171 | Q2 | 87.9% | |
| 2023 | — | — | 0.559 | Q3 | 68.5% | |
| 2022 | — | — | 0.821 | Q2 | 81.3% | |
| 2021 | — | — | 1.121 | Q2 | 88.8% | |
| 2020 | — | — | 1.883 | Q1 | 95.0% | |
| 2019 | — | — | 1.057 | Q2 | 86.9% | |
| 2018 | — | — | 1.041 | Q2 | 85.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1947-6019
ISSN
1947-6027
country
coverage
2010-2025